76 related articles for article (PubMed ID: 21162852)
1. [Progress on surveillance for invasive pneumococcal diseases in developing countries].
Luo Y; Huai Y; Yu HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Jul; 31(7):816-9. PubMed ID: 21162852
[No Abstract] [Full Text] [Related]
2. Progress and future challenges in coordinated surveillance and detection of pneumococcal and Hib disease in developing countries.
Levine OS; Cherian T; Hajjeh R; Knoll MD
Clin Infect Dis; 2009 Mar; 48 Suppl 2():S33-6. PubMed ID: 19191617
[No Abstract] [Full Text] [Related]
3. Understanding the link between pneumococcal serotypes and invasive disease.
Soley C; Arguedas A
Vaccine; 2009 Aug; 27 Suppl 3():C19-21. PubMed ID: 19535183
[TBL] [Abstract][Full Text] [Related]
4. Invasive bacterial diseases: national surveillance in Italy and vaccination coverage in the Local Health Agency 4 "Chiavarese", Liguria region (Italy).
Trucchi C; Zoppi G
J Prev Med Hyg; 2012 Jun; 53(2):120-4. PubMed ID: 23240174
[TBL] [Abstract][Full Text] [Related]
5. [Invasive pneumococcal diseases in children and surveillance systems in Italy].
Bagnato B; Marino MG; Franco E
Ig Sanita Pubbl; 2008; 64(6):811-22. PubMed ID: 19219089
[TBL] [Abstract][Full Text] [Related]
6. Challenges in estimating the impact of pneumococcal conjugate vaccines through surveillance.
Vergison A; Hanquet G
Pediatr Infect Dis J; 2012 Apr; 31(4):400-3. PubMed ID: 22418653
[No Abstract] [Full Text] [Related]
7. Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines.
von Kries R; Siedler A; Schmitt HJ; Reinert RR
Clin Infect Dis; 2000 Aug; 31(2):482-7. PubMed ID: 10987709
[TBL] [Abstract][Full Text] [Related]
8. Epidemiologic features of invasive pneumococcal disease in Belgian children: passive surveillance is not enough.
Vergison A; Tuerlinckx D; Verhaegen J; Malfroot A;
Pediatrics; 2006 Sep; 118(3):e801-9. PubMed ID: 16894008
[TBL] [Abstract][Full Text] [Related]
9. From global to regional: the importance of pneumococcal disease in Latin America.
de Quadros CA
Vaccine; 2009 Aug; 27 Suppl 3():C29-32. PubMed ID: 19540025
[TBL] [Abstract][Full Text] [Related]
10. New insights on pneumococcal disease: what we have learned over the past decade.
Dagan R
Vaccine; 2009 Aug; 27 Suppl 3():C3-5. PubMed ID: 19552985
[TBL] [Abstract][Full Text] [Related]
11. Promises and challenges of pneumococcal conjugate vaccines for the developing world.
Grijalva CG; Edwards KM
Clin Infect Dis; 2006 Sep; 43(6):680-2. PubMed ID: 16912938
[No Abstract] [Full Text] [Related]
12. Increase in invasive Streptococcus pyogenes and Streptococcus pneumoniae infections in England, December 2010 to January 2011.
Zakikhany K; Degail MA; Lamagni T; Waight P; Guy R; Zhao H; Efstratiou A; Pebody R; George R; Ramsay M
Euro Surveill; 2011 Feb; 16(5):. PubMed ID: 21315057
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal disease in Australia.
Forrest JM; McIntyre PB; Burgess MA
Commun Dis Intell; 2000 Apr; 24(4):89-92. PubMed ID: 10851795
[TBL] [Abstract][Full Text] [Related]
14. Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies.
Sniadack DH; Schwartz B; Lipman H; Bogaerts J; Butler JC; Dagan R; Echaniz-Aviles G; Lloyd-Evans N; Fenoll A; Girgis NI
Pediatr Infect Dis J; 1995 Jun; 14(6):503-10. PubMed ID: 7667055
[TBL] [Abstract][Full Text] [Related]
15. [Invasive pneumococcal disease and consolidated pneumonia in infants: one year of surveillance in three Chilean health care centers].
Abarca V K; Vergara F R; Tassara P E; Ibáñez W I; García B C; Potin S M
Rev Chilena Infectol; 2008 Apr; 25(2):97-103. PubMed ID: 18483639
[TBL] [Abstract][Full Text] [Related]
16. National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential.
Hsieh YC; Lin PY; Chiu CH; Huang YC; Chang KY; Liao CH; Chiu NC; Chuang YC; Chen PY; Chang SC; Liu JW; Yen MY; Wang JH; Liu CY; Lin TY
Vaccine; 2009 Sep; 27(40):5513-8. PubMed ID: 19615960
[TBL] [Abstract][Full Text] [Related]
17. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic-resistant pneumococci.
Raymond NJ; Grimwood K
N Z Med J; 1998 Mar; 111(1062):87-9. PubMed ID: 9577458
[No Abstract] [Full Text] [Related]
19. Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults.
Gladstone RA; Jefferies JM; Faust SN; Clarke SC
Expert Rev Vaccines; 2012 Aug; 11(8):889-902. PubMed ID: 23002969
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal vaccines: World Health Organization position paper.
Can Commun Dis Rep; 1999 Sep; 25(17):150-1. PubMed ID: 10513118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
